SCHEMBL6830772

SCHEMBL6830772

COc1ccc(Br)cc1S(=O)(=O)Nc1cccc(C(=O)N2CCCN(CC(C)C)CC2)c1

nearest known ligand 0.61

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.61
ALPL P05186 3/20 0.56
GLA P06280 1/20 0.56
CYP3A4 P08684 1/20 0.56
MAPT P10636 1/20 0.56
CYP2C9 P11712 1/20 0.56
TSHR P16473 1/20 0.56
HCRTR2 O43614 3/20 0.51
PKM P14618 2/20 0.51
LMNA P02545 3/20 0.49
POLB P06746 1/20 0.48
RAB9A P51151 1/20 0.48
HCRTR1 O43613 2/20 0.47
KDM4E B2RXH2 1/20 0.46
TP53 P04637 1/20 0.46
TRIM24 O15164 1/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
USP2 O75604 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6828049 0.89 ALDH1A1 (0.62) ALDH1A1ALPLGLACYP3A4MAPT
SCHEMBL6929713 0.88 ALDH1A1 (0.60) ALDH1A1ALPLGLACYP3A4MAPT
SCHEMBL6925877 0.86 ALDH1A1 (0.58) ALDH1A1GLACYP3A4MAPTCYP2C9
SCHEMBL3069113 0.76 ALDH1A1 (0.60) ALDH1A1GLACYP3A4MAPTCYP2C9
SCHEMBL6929296 0.75 ALDH1A1 (0.58) ALDH1A1GLACYP3A4MAPTCYP2C9
SCHEMBL6827768 0.73 ALDH1A1 (0.57) ALDH1A1GLACYP3A4MAPTCYP2C9
SCHEMBL6925065 0.73 ALDH1A1 (0.57) ALDH1A1GLACYP3A4MAPTCYP2C9
SCHEMBL6827973 0.73 PKM (0.61) ALDH1A1PKMLMNAPOLBRAB9A
SCHEMBL6925728 0.73 ALDH1A1 (0.56) ALDH1A1GLACYP3A4MAPTCYP2C9
SCHEMBL6830937 0.72 ALDH1A1 (0.60) ALDH1A1GLACYP3A4MAPTCYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004073619-A2 CCR8 ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 2004-09-02 WO claimed
WO-2004073619-A2 CCR8 ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 2004-09-02 WO disclosed